0001209191-23-018199.txt : 20230313 0001209191-23-018199.hdr.sgml : 20230313 20230313163804 ACCESSION NUMBER: 0001209191-23-018199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230309 FILED AS OF DATE: 20230313 DATE AS OF CHANGE: 20230313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fellows James R CENTRAL INDEX KEY: 0001584695 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34410 FILM NUMBER: 23727809 MAIL ADDRESS: STREET 1: 100 FEDERAL STREET STREET 2: 31ST FLOOR CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: First Eagle Alternative Capital BDC, Inc. CENTRAL INDEX KEY: 0001464963 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: SUITE 1250 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (800) 450-4424 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: SUITE 1250 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: THL Credit, Inc. DATE OF NAME CHANGE: 20090527 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-09 1 0001464963 First Eagle Alternative Capital BDC, Inc. FCRD 0001584695 Fellows James R 227 W MONROE ST., SUITE 3800 CHICAGO IL 60606 0 1 0 0 CIO of Adviser Common Stock 2023-03-09 4 D 0 144229 D 0 D On March 9, 2023, pursuant to an Agreement and Plan of Merger dated as of October 3, 2022 (the "Merger Agreement"), First Eagle Alternative Capital BDC, Inc., Crescent Capital BDC, Inc. ("CCAP"), Echelon Acquisition Sub, Inc., Echelon Acquisition Sub LLC and Crescent Cap Advisors, LLC ("CCAP Advisor") effected a merger pursuant to which CCAP acquired all of the outstanding shares of FCRDs common stock in a multi-step stock and cash transaction (the "Mergers"). Pursuant to the Merger Agreement, upon completion of the Mergers, each issued and outstanding share of FCRD common stock was converted into the right to receive a pro rata portion, subject to FCRD stockholder elections and the adjustment mechanisms set forth in the Merger Agreement with respect to the CCAP Consideration (as defined below), of (1) approximately $8.6 million in cash payable by CCAP, (2) 6,174,383 validly issued, fully paid and continued from footnote 1: non-assessable shares of CCAPs common stock, par value $0.001 per share (together, the "CCAP Consideration") and (3) $35 million in cash payable by CCAP Advisor. The disposition reported in this Form 4 is an exempt transaction. /s/ Sabrina Rusnak-Carlson as Attorney-in-Fact 2023-03-13